Health-related quality of life in cirrhotic patients: a case-control study.


Journal

La Tunisie medicale
ISSN: 2724-7031
Titre abrégé: Tunis Med
Pays: Tunisia
ID NLM: 0413766

Informations de publication

Date de publication:
Historique:
entrez: 17 3 2020
pubmed: 1 1 2019
medline: 28 8 2020
Statut: ppublish

Résumé

Assessment of health-related quality of life (HRQOL) in patients with cirrhosis has been increasingly reported in literature.  Aims: To compare quality of life scores between cirrhotic patients and healthy controls and to assess factors associated with the impairment of quality of life in cirrhotic patients. HRQOL was measured in cirrhotic patients by the Tunisian version of MOS 36-item short-form health survey (SF-36) and the Arabic version of the Liver Disease Symptom index 2.0 (LDSI2.0). Age-and sex- matched controls were asked to complete only the SF36. The SF36 scores were compared between cirrhotic patients and controls and LDSI2.0 scores were compared across cirrhotic patients according to the characteristics of cirrhosis. Factors associated with poor perceived health status were identified by logistic regression. Fifty cirrhotic patients and fifty controls were enrolled in the study. The cirrhotic group had significantly lower SF36 scores than healthy controls in all 8 dimensions (p<0.001). Most impaired LDSI items were severity of fear of complications (item 8), change in use of time (item 13), decreased sexual interest (item 14) and decreased sexual activity (item 15). Multiple logistic regression analysis showed that female sex (p=0.009), diabetes (p=0.046), treatment with diuretics (p=0.022), increased levels of serum bilirubin (p=0.045) and prolonged prothrombin time (p=0.041) were associated with poorer HRQOL. HRQOL was significantly more impaired in cirrhotic patients than controls. Female sex, diabetes, treatment with diuretics, increased levels of serum bilirubin and prolonged prothrombin time were important factors in reducing HRQOL.

Sections du résumé

BACKGROUND BACKGROUND
Assessment of health-related quality of life (HRQOL) in patients with cirrhosis has been increasingly reported in literature.  Aims: To compare quality of life scores between cirrhotic patients and healthy controls and to assess factors associated with the impairment of quality of life in cirrhotic patients.
METHODS METHODS
HRQOL was measured in cirrhotic patients by the Tunisian version of MOS 36-item short-form health survey (SF-36) and the Arabic version of the Liver Disease Symptom index 2.0 (LDSI2.0). Age-and sex- matched controls were asked to complete only the SF36. The SF36 scores were compared between cirrhotic patients and controls and LDSI2.0 scores were compared across cirrhotic patients according to the characteristics of cirrhosis. Factors associated with poor perceived health status were identified by logistic regression.
RESULTS RESULTS
Fifty cirrhotic patients and fifty controls were enrolled in the study. The cirrhotic group had significantly lower SF36 scores than healthy controls in all 8 dimensions (p<0.001). Most impaired LDSI items were severity of fear of complications (item 8), change in use of time (item 13), decreased sexual interest (item 14) and decreased sexual activity (item 15). Multiple logistic regression analysis showed that female sex (p=0.009), diabetes (p=0.046), treatment with diuretics (p=0.022), increased levels of serum bilirubin (p=0.045) and prolonged prothrombin time (p=0.041) were associated with poorer HRQOL.
CONCLUSIONS CONCLUSIONS
HRQOL was significantly more impaired in cirrhotic patients than controls. Female sex, diabetes, treatment with diuretics, increased levels of serum bilirubin and prolonged prothrombin time were important factors in reducing HRQOL.

Identifiants

pubmed: 32173847
pii: /article-medicale-tunisie.php?article=3657

Substances chimiques

Diuretics 0
Bilirubin RFM9X3LJ49

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

990-996

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH